News & Updates
Filter by Specialty:
Metformin plus R-form verapamil improves glycaemic control in T2D
Combination therapy with metformin plus R-form verapamil (R-Vera) leads to significant improvements in glycaemic control by reducing haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) among patients with type 2 diabetes (T2D), reports a study.
Metformin plus R-form verapamil improves glycaemic control in T2D
19 Oct 2022
Liver enzymes mediate association of particulate matter exposure with diabetes risk
Liver enzymes play a partial role in the relationship between exposure to particulate matter (PM) and risk of diabetes, indicating the involvement of lipid accumulation, oxidative stress, and chronic inflammation in the liver in its pathogenesis, reports a recent study.
Liver enzymes mediate association of particulate matter exposure with diabetes risk
19 Oct 2022
Vitamin A intake helps prevent diabetes onset in adults
People who have enough vitamin A intake are less likely to develop diabetes, and this benefit is more pronounced among men, reports a study of Chinese adults with plant-based diets.
Vitamin A intake helps prevent diabetes onset in adults
18 Oct 2022
Diabetes-related amputations on the decline in Singapore
Between 2013 and 2020, lower extremity amputations (LEA) due to diabetes mellitus (DM) showed a downward trend, according to a recent Singapore study. However, other cardiovascular complications, including peripheral arterial disease (PAD) and ischaemic heart disease (IHD), remain prominent public health concerns.
Diabetes-related amputations on the decline in Singapore
18 Oct 2022
Skipping meal tied to increased fat deposition in type 2 diabetes
Among patients with type 2 diabetes (T2D), those who eat two meals per day exhibit higher greater intrapancreatic fat deposition than those who consume three meals per day, a study has found.
Skipping meal tied to increased fat deposition in type 2 diabetes
15 Oct 2022
First-line SGLT2 inhibitors, GLP1 receptor agonists need to cut price to be cost-effective
First-line treatment with sodium–glucose cotransporter-2 (SGLT2) inhibitors or glucagon-like peptide-1 (GLP1) receptor agonists improves outcomes in patients with type 2 diabetes (T2D), but to be cost-effective, the prices of these drugs must drop by at least 70 percent, suggests a study.
First-line SGLT2 inhibitors, GLP1 receptor agonists need to cut price to be cost-effective
15 Oct 2022
DIY diabetes management with digital app facilitates better weight, blood sugar control
Self-management of diabetes through smartphone heath app engagement appears to bring positive changes in disease outcomes such as weight and blood sugar, according to data from the Diabetes Lifestyle Intervention using Technology Empowerment (D’LITE) study.
DIY diabetes management with digital app facilitates better weight, blood sugar control
14 Oct 2022
Maternal ultra-processed food intake ups risk of childhood obesity
Mothers who regularly eat ultra-processed foods during the child-rearing period appear to increase the risk of overweight or obesity in their children, irrespective of maternal and offspring lifestyle risk factors, a study has shown.